TGA approves new treatment for aggressive form of prostate cancer

Cassandra Morgan
Updated May 5 2021 - 6:52pm, first published 12:01am

The Therapeutic Goods Administration has registered a new medication to treat a particularly aggressive and advanced type of prostate cancer.

Subscribe now for unlimited access.

$0/

(min cost $0)

or signup to continue reading

See subscription options
Cassandra Morgan

Cassandra Morgan

Canberra Times health reporter

It has never been more important for Canberrans to be able to access reliable and accurate information about health. As The Canberra Times’ health reporter, I am committed to ensuring our readers have access to this. I, like many in the territory, have family members who work in the sector. Although providing comprehensive coverage on the coronavirus pandemic is obviously my number one priority, I aim to frequently shed light on the fantastic work our frontline professionals do, as well as the challenges they face. Email me tips and story ideas at: c.morgan@canberratimes.com.au.